Ifsofamide and Hyperparathyroidism primary - a phase IV clinical study of FDA data

Summary:

We study 1,365 people who take Ifsofamide (ifosfamide) or have Hyperparathyroidism primary. No report of Hyperparathyroidism primary is found in people who take Ifsofamide.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What is Ifsofamide?

Ifsofamide has active ingredients of ifosfamide. eHealthMe is studying from 5 Ifsofamide users. Check the latest studies of Ifsofamide.

What is Hyperparathyroidism Primary?

Hyperparathyroidism primary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium- primary) is found to be associated with 55 drugs and 132 conditions by eHealthMe. Check the latest studies of Hyperparathyroidism primary.

On Feb, 15, 2026

No report is found.

Do you take Ifsofamide and have Hyperparathyroidism primary?

- Check whether Hyperparathyroidism primary is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ifsofamide:

Ifsofamide (5 reports)

Browse all side effects of Ifsofamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperparathyroidism primary:

Hyperparathyroidism primary

Browse all the conditions that are associated with Hyperparathyroidism primary:

Hyperparathyroidism primary

How the study uses the data?

The study uses data from the FDA. It is based on ifosfamide (the active ingredients of Ifsofamide) and Ifsofamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.